Peter Lamprecht Selected Research

Prednisolone (Predate)

6/2023

Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Lamprecht Research Topics

Disease

29	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 03/2024 - 05/2002
28	Vasculitis (Vasculitides) 04/2024 - 02/2004
17	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 04/2024 - 09/2004
14	Inflammation (Inflammations) 03/2024 - 05/2008
9	Autoimmune Diseases (Autoimmune Disease) 03/2024 - 01/2003
9	Churg-Strauss Syndrome (Allergic Angiitis) 04/2023 - 01/2005
8	Infections 02/2023 - 12/2009
6	Giant Cell Arteritis (Horton Disease) 06/2023 - 01/2005
6	Microscopic Polyangiitis 01/2023 - 01/2005
6	Systemic Vasculitis 01/2018 - 01/2005
4	Granuloma 06/2009 - 05/2002
3	Hypertension (High Blood Pressure) 06/2023 - 01/2010
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023 - 01/2005
2	Fever (Fevers) 01/2023 - 01/2018
2	Disease Progression 11/2022 - 12/2005
2	IgA Vasculitis (Purpura, Schoenlein Henoch) 05/2022 - 01/2018
2	Systemic Scleroderma (Systemic Sclerosis) 01/2021 - 12/2018
2	Crohn Disease (Crohn's Disease) 04/2009 - 06/2006
2	Rheumatoid Arthritis 03/2009 - 01/2005
2	Connective Tissue Diseases (Connective Tissue Disease) 02/2006 - 01/2005
1	Nasopharyngitis 06/2023
1	Exanthema (Rash) 01/2023
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2023
1	Polyarteritis Nodosa (Periarteritis Nodosa) 01/2023
1	Schnitzler Syndrome 01/2023
1	Arthralgia (Joint Pain) 01/2023
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2023
1	Peritoneal Panniculitis (Sclerosing Mesenteritis) 11/2022
1	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 05/2022
1	Rheumatic Diseases (Rheumatism) 01/2021
1	Cytopenia 01/2020
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 12/2018
1	Alzheimer Disease (Alzheimer's Disease) 12/2018
1	Erdheim-Chester Disease 03/2018
1	Tertiary Lymphoid Structures 01/2018
1	Leukopenia 03/2016
1	Diabetes Mellitus 05/2013
1	Cataract (Cataracts) 05/2013
1	Osteoporosis 05/2013

Drug/Important Bio-Agent (IBA)

22	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 04/2024 - 02/2004
13	AutoantibodiesIBA 02/2023 - 03/2006
10	Myeloblastin (Proteinase 3)IBA 03/2024 - 02/2004
8	CytokinesIBA 10/2012 - 05/2002
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2016 - 02/2004
5	Peptide Hydrolases (Proteases)FDA Link 03/2024 - 01/2010
5	AutoantigensIBA 02/2023 - 06/2006
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2009 - 05/2002
3	Peroxidase (Myeloperoxidase)IBA 03/2024 - 01/2010
3	C-Reactive ProteinIBA 01/2023 - 01/2011
3	Antigen-Antibody Complex (Immune Complex)IBA 01/2023 - 03/2006
3	AntibodiesIBA 01/2023 - 03/2009
3	Rituximab (Mabthera)FDA Link 01/2020 - 04/2006
3	Azathioprine (Imuran)FDA LinkGeneric 03/2006 - 09/2004
2	EnzymesIBA 03/2024 - 03/2016
2	AntigensIBA 03/2024 - 04/2023
2	GlucocorticoidsIBA 06/2023 - 01/2012
2	secukinumabIBA 06/2023 - 08/2021
2	Immunoglobulin G (IgG)IBA 01/2023 - 12/2018
2	Interferon-gamma (Interferon, gamma)IBA 08/2021 - 05/2002
2	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2013 - 02/2004
1	tocilizumab (atlizumab)FDA Link 06/2023
1	Monoclonal AntibodiesIBA 06/2023
1	Prednisolone (Predate)FDA LinkGeneric 06/2023
1	Environmental Pollutants (Pollutants, Environmental)IBA 02/2023
1	Immunoglobulin M (IgM)IBA 01/2023
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2023
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2023
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	Complement C5a (Complement 5a)IBA 01/2023
1	elotuzumabIBA 11/2022
1	HMGB1 Protein (HMG1)IBA 01/2022
1	Contrast MediaIBA 08/2021
1	InterleukinsIBA 08/2021
1	Antimicrobial PeptidesIBA 06/2021
1	Interleukin-2 (IL2)IBA 01/2021
1	HLA-DQ Antigens (HLA-DQ)IBA 11/2019
1	Endothelin Receptors (Endothelin Receptor)IBA 10/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2018
1	Antinuclear AntibodiesIBA 03/2018
1	Antirheumatic Agents (DMARD)IBA 01/2018
1	Prednisone (Sone)FDA LinkGeneric 01/2018
1	Cytochrome P-450 CYP2C9IBA 03/2016
1	Cytochrome P-450 CYP2C19IBA 03/2016
1	ProdrugsIBA 03/2016
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 03/2016
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2013
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2012
1	Interleukin-7 (Interleukin 7)IBA 01/2012
1	Interleukin-15 Receptors (Interleukin 15 Receptor)IBA 01/2012
1	SuperantigensIBA 01/2010
1	PAR-2 ReceptorIBA 01/2010

Therapy/Procedure

14	Therapeutics 04/2024 - 02/2004
2	Biological Therapy 06/2023 - 04/2007
1	Immunotherapy 03/2024
1	Aftercare (After-Treatment) 08/2021
1	Extracorporeal Membrane Oxygenation 01/2021
1	Transplantation 05/2012